475 Sustained virological response (SVR) to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (Roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C (CHC)
- 31 December 2004
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 40, 140
- https://doi.org/10.1016/s0168-8278(04)90475-8
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: